A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil

PHASE3CompletedINTERVENTIONAL

Enrollment

222

Participants

Timeline

Start Date

April 27, 2015

Primary Completion Date

July 4, 2016

Study Completion Date

September 26, 2016

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG

ombitasvir/paritaprevir/ritonavir and dasabuvir

Tablet; ombitasvir coformulated with paritaprevir and ritonavir, dasabuvir tablet

DRUG

ribavirin

Tablet